Prostate Cancer - Results from #19580

Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: An early experience - Abstract December 8, 2014

First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection - Abstract December 8, 2014

Prostate cancer prophylaxis by dietary supplements: More than just an illusion? - Abstract December 8, 2014

Rapid Arc, helical tomotherapy, sliding window intensity modulated radiotherapy and three dimensional conformal radiation for localized prostate cancer: A dosimetric comparison - Abstract December 8, 2014

Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: A Scottish experience - Abstract December 8, 2014

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: The critical role of the pathologist - Abstract December 8, 2014

Who dies from prostate cancer? - Abstract December 5, 2014

Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: Results from a privately insured patient population - Abstract December 5, 2014

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: Results of a randomized phase II neoadjuvant study - Abstract December 5, 2014

#SUO14 - Session Highlights: Sequencing prior to chemotherapy December 5, 2014

Localised prostate cancer and hemophilia A (AHA): Case report and management of the disease - Abstract December 5, 2014

Models of assessment of comparative outcomes of robot-assisted surgery: Best evidence regarding the superiority or inferiority of robot-assisted radical prostatectomy - Abstract December 5, 2014

The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy - Abstract December 5, 2014

#SUO14 - Session Highlights: What is the impact of ECOG 3805 (CHAARTED) results on clinical practice? December 5, 2014

#SUO14 - Session Highlights: Non-genomic AR pathway December 5, 2014

#SUO14 - Session Highlights: FSH and the metabolic syndrome December 5, 2014

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN) - Abstract December 5, 2014

End points of clinical trials in metastatic castration-resistant prostate cancer: A systematic review - Abstract December 5, 2014

Particle radiotherapy for prostate cancer - Abstract December 5, 2014

#SUO14 - Session Highlights: Declining rate of prostate biopsy in the Veterans Health Administration in the past decade: An alternate approach to limiting overdiagnosis and overtreatment of prostate cancer? December 5, 2014

Page 980 of 1454